Philip Wai‐Kay Kwong

Queen Mary Hospital

Papers

1

Total Citations

8

H-Index

1

About

Philip Wai‐Kay Kwong is a leading urological oncologist whose research focuses on prostate cancer management, particularly during public health crises. His most cited work, a 2021 paper co-authored with the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology, provides critical recommendations for prostate cancer care amid the COVID-19 pandemic. This paper, with 8 citations, addresses the urgent need for interdisciplinary coordination to manage patients across different disease stages during global disruptions. Dr. Kwong’s contributions have shaped clinical guidelines that balance cancer treatment continuity with pandemic safety protocols, ensuring that patients receive timely, evidence-based care even under resource constraints. His expertise extends to uro-oncology more broadly, where he advocates for adaptive strategies in cancer management. Through this notable work, Dr. Kwong has demonstrated how specialized medical societies can rapidly respond to emerging challenges, influencing both local and international practices. His research underscores the importance of resilience in healthcare systems, making him a key figure in the intersection of oncology and public health preparedness.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Queen Mary Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago